Intermittent dosing with sunitinib (Pf-02783926) and docetaxel provides effective therapy against lytic bone metastasis of human breast cancerCedo M Bagi,Edwin Berryman,Catharine J AndresenBONE（2012）引用 2|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
